Shukra Medtech Limited has issued a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited intimating them of an upcoming Board of Directors meeting.
The meeting is scheduled to be held on Tuesday, November 3, 2026 at the Registered Office of the Company located at 3rd Floor, \"VEER HOUSE\" Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054.
The primary agenda for the board meeting includes:
- Consideration and approval of the unaudited financial results for the second quarter and half year ended on September 30, 2026
- Consideration and approval of the Auditor's Limited Review Report for the same period
- Any other business with the permission of the Chairman
The disclosure is made pursuant to Regulation 29 read with other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's CIN is L24231GJ1993PLC019079.